Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel and prednisone, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. It
is not yet known which schedule of docetaxel and prednisone is more effective in treating
prostate cancer.
PURPOSE: This randomized phase III trial is studying two different schedules of docetaxel and
prednisone to compare how well they work in treating patients with metastatic prostate
cancer.